Market Research Logo

Global Animal Health Partnering Terms and Agreements 2012 to 2018

Global Animal Health Partnering Terms and Agreements 2012 to 2018
Welcome to the Global Animal Health Partnering Terms and Agreements 2012 to 2018 report.

The report provides a detailed understanding and analysis of how and why companies enter Animal Health partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Animal Health agreements announced in the life sciences since 2012.

The report takes the reader through a comprehensive review Animal Health deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Animal Health partnering deals.

The report presents financial deal term values for Animal Health deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Animal Health partnering field; both the leading deal values and most active Animal Health dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 400 online deal records of actual Animal Health deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Animal Health dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Animal Health dealmaking since 2012, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Animal Health deals since 2012. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Animal Health dealmaking with a brief summary followed by a comprehensive listing of Animal Health deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Animal Health partnering deals signed and announced since Jan 2012, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Animal Health partnering deals signed and announced since Jan 2012. The chapter is organized by specific Animal Health technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Animal Health partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Animal Health partnering and dealmaking since 2012.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Animal Health technologies and products.

Key benefits

Global Animal Health Partnering 2012-2018: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

In-depth understanding of Animal Health deal trends since 2012
Access to headline, upfront, milestone and royalty data
Analysis of the structure of Animal Health agreements with real life case studies
Detailed access to actual Animal Health contracts entered into by leading biopharma companies
Identify most active Animal Health dealmakers since 2012
Insight into terms included in a Animal Health partnering agreement, with real world examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Animal Health Partnering 2012-2018: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Animal Health trends and structure of deals entered into by leading companies worldwide.

Animal Health Partnering Terms and Agreements includes:

Trends in Animal Health dealmaking in the biopharma industry since 2012
Analysis of Animal Health deal structure
Access to headline, upfront, milestone and royalty data
Case studies of real-life Animal Health deals
Access to Animal Health contract documents
Leading Animal Health deals by value since 2012
Most active Animal Health dealmakers since 2012

In Global Animal Health Partnering 2012-2018: Deal trends, players, financials and forecasts, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Animal Health Partnering 2012-2018: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 400 Animal Health deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in Animal Health dealmaking
    • Introduction
    • Animal Health partnering over the years
    • Most active Animal Health dealmakers
    • Animal Health partnering by deal type
    • Animal Health partnering by therapy area
    • Animal Health partnering by technology type
    • Deal terms for Animal Health partnering
      • Animal Health partnering headline values
        • Table Animal Health deals with a headline value
      • Animal Health deal upfront payments
        • Table Animal Health deals with an upfront value
      • Animal Health deal milestone payments
        • Table Animal Health deals with a milestone value
      • Animal Health royalty rates
        • Table Animal Health deals with a royalty rate value
  • Leading Animal Health deals
    • Introduction
    • Top Animal Health deals by value
      • Table Top Animal Health deals by value since 2012
  • Most active Animal Health dealmakers
    • Introduction
    • Most active Animal Health dealmakers
    • Most active Animal Health partnering company profiles
      • Pfizer
      • Zoetis
      • Boehringer Ingelheim
      • Merck and Co
      • Nexvet
      • Sanofi
      • Elanco
      • Lonza
      • Jaguar Health
      • Aratana Therapeutics
      • Merial
      • Neogen
      • Abaxis
      • Abbott Laboratories
      • MWI Veterinary Supply
      • Scynexis
      • Virbac
      • Vivalis
      • Bayer
      • Bioniche Life Sciences
      • IDEXX Laboratories
      • Oragenics
      • Anatara Lifesciences
      • BioNeutral
      • Boehringer Ingelheim Vetmedica
  • Animal Health contracts dealmaking directory
    • Introduction
    • Animal Health contracts dealmaking directory
  • Animal Health dealmaking by technology type
    • Adjuvant
    • Analysis
    • Animal models
    • Antibiotics
    • Macrolides
    • Antibodies
    • Antibody-drug conjugate
    • Monoclonal antibodies
    • Humanized mAb
    • Human mAb
    • Assays
    • Bioinformatics
    • Biological compounds
    • Biomarkers
    • Bioprocessing
    • Blood products
    • Cell culture
    • Clinical testing
    • CRISPR
    • Devices
    • Surgical devices
    • Wearable devices
    • Diagnostics
    • Companion
    • Imaging
    • CT
    • Ultrasound
    • X-ray
    • In vitro diagnostics
    • Molecular diagnostics
    • Discovery tools
    • Compound screening library
    • High throughput screening (HTS)
    • Drug delivery
    • Bioavailability
    • Oral delivery
    • Delayed release
    • Rapid release
    • Parenteral
    • Infusion
    • Injectable
    • Pro-drug
    • Targeted
    • Topical
    • Inhaled
    • Ocular
    • Enabling technology
    • Enviromental
    • Equipment
    • Facilities
    • Gene therapy
    • Genomics
    • Industrial chemicals
    • Microarray
    • Microbiome
    • Natural product
    • Peptides
    • Personalised medicine
    • Pharmacogenomics
    • Precision medicine
    • Probiotics
    • Proteomics
    • Radio/Chemo-therapy
    • Regenerative medicine
    • Anti-aging
    • Cell therapy
    • Organ regeneration
    • Stem cells
    • Tissue regeneration
    • Research services
      • Research supplies
      • RNA therapeutics
      • Screening
      • Small molecules
      • Software tools
      • Toxicity
      • Vaccines
      • Conjugate vaccine
      • Inactivated vaccine
      • DNA vaccine
  • Partnering resource center
    • Online partnering
    • Partnering events
    • Further reading on dealmaking
  • Appendices
    • Animal Health deals by company A-Z
      • 23andMe
      • Abaxis
      • Abbott Laboratories
      • Abbvie
      • Abide Therapeutics
      • Ablynx
      • Absorption Systems
      • ABS Global
      • Ab E Discovery
      • Actavis (name changed to Allergan)
      • Actelion
      • Actinobac Biomed
      • Adisseo
      • Advanced Animal Diagnostics
      • Advanced BioNutrition
      • Advanced Radiation Therapy
      • Advaxis
      • Affymetrix
      • Agenix
      • Agenus Bio
      • Agricultural Research Service
      • AKC Canine Health Foundation
      • Allegheny General Hospital
      • Allogene Therapeutics
      • Alphavax
      • Alpha Tech Pet
      • American College of Emergency Physicians
      • American College of Physicians Foundation
      • American Diabetes Association
      • American Heart Association
      • AmeriCares
      • Amgen
      • Anacor Pharmaceuticals
      • Anapure BioScientific
      • Anatara Lifesciences
      • Anika Therapeutics
      • Animal Clinical Investigation
      • Applied Genetics
      • Aptimmune Biologics
      • Aqua Gen
      • Arabio
      • Aratana Therapeutics
      • Arcadia Biosciences
      • Arcturus Therapeutics
      • Ark Animal Health
      • Artes Biotechnology
      • Arysta LifeScience
      • AskAt
      • AspenBio Pharma
      • AstraZeneca
      • Atopix
      • Auburn University
      • Aurinia Pharmaceuticals
      • AvidBiotics
      • Avista Pharma Solutions
      • Avivagen
      • Avon Foundation
      • Banfield Pet Hospital
      • Bayer
      • Bayer Animal Health
      • Bayer Healthcare
      • BeiGene
      • Bio-X Diagnostics
      • Biogal-Galed Labs
      • BioHeart
      • BioNeutral
      • Bioniche Life Sciences
      • BioNTech
      • BioRestorative Therapies
      • Biosciences Eastern and Central Africa - International Livestock Research Institute Hub
      • Bioseed Research India
      • Biotechnology and Biological Sciences Research Council (BBSRC)
      • Bio Architecture Lab
      • Boehringer Ingelheim
      • Boehringer Ingelheim Vetmedica
      • Boston Therapeutics
      • Branhaven
      • Bristol-Myers Squibb
      • Broad Institute
      • Butler Schein Animal Health
      • Cambridge Biolabs
      • Cargill
      • Caribou Biosciences
      • Carl Zeiss Meditec
      • Catalent Pharma Solutions
      • Cellectis
      • Cellmid
      • Celsee
      • Cempra Pharmaceutical
      • Central Institute for Experimental Animals
      • Centre for Integrative Genetics
      • Centrovet
      • Centrovet Laboratories
      • Ceva Sante Animale
      • China Animal Husbandry Industry
      • Chinese Veterinary Medical Association
      • ChromaDex
      • Cimtech
      • Cipla
      • CliniWorks
      • Cobb-Vantress
      • Companion PBx
      • Connexios
      • Cook Medical
      • Covenant Animal Health Partners
      • CryoPort
      • Crystal Bioscience
      • CTX Technology
      • CureVac
      • CURE Pharmaceutical
      • D-Eye
      • Dainippon Sumitomo Pharma
      • Dako
      • Dechra Pharmaceuticals
      • Decision Diagnostics
      • DEG Productions
      • Deltamune
      • Department of Homeland Security
      • DKSH
      • Donald Danforth Plant Science Center
      • Dosch Pharmaceuticals
      • Dow AgroSciences
      • DSM
      • DSM Nutritional Products
      • Duke Clinical Research Institute (DCRI)
      • DuPont
      • Edison Pharmaceuticals
      • Elanco
      • Eli Lilly
      • EmbryoTrans Biotech
      • Emcure Pharmaceuticals
      • EMD Serono
      • Emergent BioSolutions
      • Entest BioMedical
      • Epica Medical Innovations
      • Epilepsy Foundation (EF)
      • Epitomics
      • Ethos Veterinary Health
      • Eureka Genomics
      • Eurofins Scientific
      • European Commission
      • Evonik Industries
      • Fabentech
      • Farvet Farmacologicos Veterinarios
      • FASTVet
      • Feinstein Institute for Medical Research
      • Ferring Pharmaceuticals
      • Fonterra
      • Food and Drug Administration (FDA)
      • Fortified Management Group
      • Fresno
      • FuturaGene
      • Galmed Pharmaceuticals
      • Genclis
      • Genentech
      • Generosus Advisors
      • GeneSeek
      • Gentel Biosciences
      • Genus
      • Georgia Institute of Technology
      • GE Healthcare
      • Glanbia Nutritionals
      • GlaxoSmithKline
      • Glenmark Pharmaceuticals
      • Global Green
      • Glykos
      • Godrej
      • Gour Medical
      • Greer
      • Hanmi Pharmaceutical
      • Harrisvaccines
      • Health Enhancement Products
      • Heart Rhythm Society
      • Hendrix Genetics
      • Henry Schein
      • Heska
      • Hippolia
      • Humane Society
      • Hurel
      • Huvepharma
      • Hydra Biosciences
      • Ichor Medical Systems
      • Icon
      • IDEXX Laboratories
      • Illumina
      • Imagilin Technology
      • Imaxio
      • Imperial College London
      • In-Vivo Science International
      • Incyte
      • India Globalization Capital
      • Innovet
      • InnoVision Therapeutics
      • Inovalon
      • Inovio Pharmaceuticals
      • InQpharm
      • Inserm
      • Institute for the Promotion of Innovation by Science and Technology in Flanders
      • Institut National Recherche Agronomique
      • InstrAction
      • Integrated Animal Health
      • Intellimedix
      • International Crops Research Institute for the Semi-Arid Tropics
      • International Veterinary Collaboration for China
      • Intrexon
      • Intuitive Bio
      • Invitrx Therapeutics
      • In Cell Art
      • Iowa State University
      • Isconova
      • Itamar Medical
      • IVF Bioscience
      • Jaguar Health
      • Jianshun Biosciences
      • Johns Hopkins University
      • Joslin Diabetes Center
      • JP Equine Services
      • Juvenile Diabetes Research Foundation
      • Kansas State University
      • KBI BioPharma
      • Keck Graduate Institute of Applied Life Sciences
      • Kemin Industries
      • Kindred Bio
      • Kings College London
      • KMG Chemicals
      • Kyoto Biken
      • Kyowa Hakko Kirin
      • Laboratorios Bago
      • Leica Microsystems
      • LexaGene
      • LifeArc
      • Life Technologies Corporation
      • Ligand Pharmaceuticals
      • Lincoln Equities Group
      • LiveLeaf
      • Lonza
      • Lumleian
      • Lumosa Therapeutics
      • Lysando
      • Manna Research
      • MannKind Biopharmaceuticals
      • Marina Biotech
      • Marrone Bio Innovations
      • MaRS Innovation
      • Masimo
      • Massachusetts Institute of Technology
      • Med-Pharmex
      • MedGenesis Therapeutix
      • MediCann Handels
      • MediSapiens
      • Medivir
      • Medline Industries
      • Medtronic
      • Meiji Seika
      • Menzer
      • Merck and Co
      • Merck Animal Health
      • Merial
      • Metabolix
      • Metanome
      • MILA International
      • Milo Biotechnology
      • Mimetas
      • Minnesota Department of Health
      • Mississippi State University
      • Mitsubishi Tanabe Pharma
      • MJ Biologics
      • Mount Sinai Medical Center
      • MSD Animal Health
      • MWI Veterinary Supply
      • MyoKardia
      • MYOS
      • NanoString Technologies
      • Napo Pharmaceuticals
      • National Centre for the Replacement, Refinement and Reduction of Animals in Research
      • National Distribution & Contracting
      • National Institutes of Health
      • National Institute of Arthritis and Musculoskeletal Diseases
      • National Institute of Food and Agriculture
      • National Institute of Neurological Disorders and Stroke
      • National Institute on Aging
      • National Psoriasis Foundation
      • National Research Council Canada
      • Neogen
      • Neogen NV
      • Neptune Technologies & Bioressources
      • NewMarket Pharmaceuticals
      • Nexvet
      • Nong Lam University
      • Northwest Missouri State University
      • North Carolina Biotechnology Center
      • North Carolina State University
      • NovaBay Pharmaceuticals
      • Novartis
      • Novartis Animal Health
      • Novozymes
      • Novus International
      • Nrgene
      • Nuevolution
      • Nuovo Biologics
      • NutraMax
      • Nutra Pharma
      • Nutricion Avanzada
      • NutriQuest
      • Nyco Products Company
      • Oculus Innovative Sciences
      • Ohio State University
      • Okapi Sciences
      • One Way Liver Genomics (OWL)
      • Oragenics
      • Organic Wave
      • OSEO
      • Pacira Pharmaceuticals
      • Pall Corporation
      • Parnell Pharmaceutical Holdings
      • Patheon
      • Pathway Therapeutics
      • Peak Pharmaceuticals
      • PetLife Pharmaceuticals
      • Pet Pointers
      • Pfizer
      • Pfizer Animal Health
      • Pharmacos Exakta
      • Pharma Tech Solutions
      • Phenomenex
      • Phibro Animal Health
      • Phosphagenics
      • Piedmont Pharmaceuticals
      • Pinnaclife
      • Plandai Biotechnology
      • Platinum Performance
      • Plumbline Life Sciences
      • Premune
      • Prevtec Microbia
      • Prima Tech
      • Prionics
      • ProBioGen
      • ProBiora Health
      • Process Systems Enterprise
      • Provectus Biopharmaceuticals
      • Purina
      • Q-Biologicals
      • Queen Mary University of London
      • Recipharm
      • Redbarn Pet Products
      • Regeneron Pharmaceuticals
      • Regeneus
      • Regents of the University of Michigan
      • Regen BioPharma
      • Reliance Animal Health Partners
      • Retrophin
      • Roche
      • Rosa
      • Roslin Institute
      • Rutgers University
      • Saniona
      • Sanofi-Pasteur
      • Sanofi
      • Santen Pharmaceutical
      • Sciex
      • Scil Animal Care
      • Scripps Research Institute
      • Scynexis
      • Seed Mena
      • Selecta Biosciences
      • Senestech
      • Sepha
      • SeQuent Scientific
      • Servier
      • Sexing Technologies
      • Sharp Edge Labs
      • Shasun Pharmaceuticals
      • Skyline Vet Pharma
      • Smithsonian National Zoo
      • Sono-Tek
      • Sorrento Therapeutics
      • Spectrum Group
      • Stemlogix
      • Stony Brook University
      • St Georges University of London
      • Sun Pharmaceutical
      • Swansea University
      • Synthetic Genomics
      • Sysmex Inostics
      • Taconic
      • Technology Acceleration Partners
      • Tetrahedron
      • Tetra Bio-Pharma
      • Teva Pharmaceutical Industries
      • Texas Tech University
      • Theragenics
      • Thermo Fisher Scientific
      • Thrive Bioscience
      • Traverse Biosciences
      • Trophogen
      • Tyrian Diagnostics
      • Unilife
      • Universidad National Autonoma de Mexico
      • University Health Network
      • University of Cambridge
      • University of Glasgow
      • University of Helsinki
      • University of London
      • University of Massachusetts
      • University of Minnesota
      • University of Missouri
      • University of Oxford
      • University of Pennsylvania
      • University of Texas
      • University of Toronto
      • University of Veterinary Medicine of Hannover
      • US Department of Agriculture
      • Valneva
      • VCA Antech
      • Vedco
      • Verenium
      • Verios Agro
      • VERT
      • Vet-Stem
      • Vetcare
      • VetDC
      • Virbac
      • Vium
      • Vivaldis
      • Vivalis
      • Waterstone Pharmaceutical
      • WomenHeart
      • World Health Organization
      • X-chem
      • XL-Protein
      • Xunshan
      • Yancey Farms
      • Zander Therapeutics
      • Zenoaq
      • Zhejiang Hisun Pharmaceutical
      • Zivo Bioscience
      • Zoetis
      • Zomedica
      • Zydus Cadila
    • Animal Health deals by stage of development
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
      • Formulation
    • Animal Health deals by deal type
      • Asset purchase
      • Bigpharma outlicensing
      • Co-development
      • Collaborative R&D
      • Co-market
      • Co-promotion
      • CRADA
      • Development
      • Distribution
      • Equity purchase
      • Evaluation
      • Grant
      • Joint venture
      • Licensing
      • Manufacturing
      • Marketing
      • Option
      • Promotion
      • Research
      • Settlement
      • Spin out
      • Supply
      • Termination
    • Animal Health deals by therapy area
      • Respiratory depression
      • Cardiovascular
      • Atrial fibrillation
      • Cardiomyopathy (heart muscle disease)
      • Congestive heart failure
      • Hypertension
      • Thrombus (blood clot)
      • Central Nervous System
      • Epilepsy
      • Meningitis
      • Nausea
      • Neuropathy
      • Pain
      • Neuralgia
      • Parkinson's disease
      • Stroke
      • Dental
      • Dental caries
      • Oral health
      • Periodontal disease
      • Xerostomia
      • Dermatology
      • Dermatitis
      • Hair disorders
      • Psoriasis
      • Wound healing
      • Gastrointestinal
      • Inflammatory bowel disease
      • Crohn's disease
      • Diarrhea
      • Genetic disorders
      • Rare genetic disorders
      • Chronic kidney disease (CKD)
      • Diabetic nephropathy
      • Renal failure
      • Urinary tract infection (UTI)
      • Infertility
      • Hematology
      • Hospital care
      • Surgery
      • Immunology
      • Allergy
      • Graft versus host disease
      • Inflammation
      • Systemic lupus erythematosus
      • Infectives
      • Bacterial
      • Escherichia Coli (E-coli)
      • Mycobacterium avium
      • Salmonella
      • Tuberculosis (TB)
      • Fungal
      • Parasitic
      • Tropical
      • Viral
      • Foot and mouth disease
      • Herpes simplex
      • HIV
      • Respiratory syncytial virus (RSV)
      • Diabetes
      • Type 1
      • Type 2
      • Liver disease
      • Nonalcoholic steatohepatitis (NASH)
      • Nutrition and vitamins
      • Musculoskeletal
      • Arthritis
      • Osteoarthritis
      • Psoriatic arthritis
      • Rheumatoid arthritis
      • Symptoms
      • Bone pain
      • Muscular pain
      • Hemorrhage
      • Oncology
      • Breast cancer
      • Colorectal cancer
      • Head and neck cancer
      • Kidney cancer
      • Leukemia
      • Lung cancer
      • Non small cell lung cancer
      • Melanoma
      • Metastases
      • Renal cell carcinoma
      • Solid tumors
      • Symptoms
      • Ophthalmics
      • Cataracts
      • Dry eye
      • Orphan disease
      • Pediatrics
      • Anxiety disorder
      • Alzheimers
      • Obesity
      • Chronic obstructive pulmonary disease
      • Idiopathic pulmonary fibrosis
      • Pulmonary arterial hypertension
      • Candida albicans (Thrush)
      • Erectile dysfunction
    • Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from Current Partnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report